HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Didier Desmaele Selected Research

Rhenium

4/2020A New Model Applied for Evaluating a Rhenium-diselenium Drug: Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPS.
10/2019The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.
1/2019Design of Rhenium Compounds in Targeted Anticancer Therapeutics.
11/2016Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated Administrations.
11/2016Negative Impact of Total Body Irradiation on the Antitumor Activity of Rhenium-(I)-diselenoether.
7/2012Combination of three metals for the treatment of cancer: gallium, rhenium and platinum. 1. Determination of the optimal schedule of treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Didier Desmaele Research Topics

Disease

12Neoplasms (Cancer)
04/2020 - 12/2007
5Breast Neoplasms (Breast Cancer)
04/2020 - 07/2012
3Neoplasm Metastasis (Metastasis)
05/2015 - 11/2008
2Papillary Thyroid Cancer
01/2014 - 06/2011
2Leukemia
11/2008 - 12/2007
1Infections
01/2020
1Colonic Neoplasms (Colon Cancer)
10/2019
1Triple Negative Breast Neoplasms
10/2019
1Uterine Neoplasms (Uterine Cancer)
10/2019
1Phototoxic Dermatitis (Phototoxicity)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2016
1Prostatic Neoplasms (Prostate Cancer)
05/2015
1Bone Neoplasms (Bone Cancer)
05/2015
1Large Granular Lymphocytic Leukemia
11/2008
1Leukemia L1210
12/2007

Drug/Important Bio-Agent (IBA)

6RheniumIBA
04/2020 - 07/2012
4Pharmaceutical PreparationsIBA
04/2020 - 11/2008
4GemcitabineFDA Link
11/2016 - 12/2007
2Alkylating AgentsIBA
11/2017 - 01/2015
2SqualeneIBA
06/2015 - 06/2011
2Small Interfering RNA (siRNA)IBA
01/2014 - 06/2011
24-(N)-tris-nor-qualenoyl-gemcitabineIBA
11/2008 - 12/2007
1CytokinesIBA
04/2020
1HydrogenIBA
01/2020
1Sulfates (Sulfates, Inorganic)IBA
01/2020
1Tobramycin (Nebcin)FDA LinkGeneric
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Hormones (Hormone)IBA
10/2019
1LigandsIBA
10/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1EnzymesIBA
01/2019
1trofosfamideIBA
11/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017
1IfosfamideFDA LinkGeneric
11/2017
1SeleniumIBA
11/2016
1Tyrosine Kinase InhibitorsIBA
11/2016
1Sunitinib (Sutent)FDA Link
11/2016
1AcidsIBA
06/2015
1DeoxycytidineIBA
06/2015
1Cisplatin (Platino)FDA LinkGeneric
05/2015
1Durapatite (Hydroxylapatite)IBA
05/2015
1ProdrugsIBA
11/2013
1Paclitaxel (Taxol)FDA LinkGeneric
11/2013
1Firefly LuciferasesIBA
11/2013
1cremophorIBA
11/2013
1PlatinumIBA
07/2012
1GalliumIBA
07/2012
1SalicylatesIBA
07/2012
1Ether (Diethyl Ether)IBA
07/2012
1LipidsIBA
06/2011
1Oncogene Proteins (Oncogene Protein)IBA
06/2011
1Cytidine DeaminaseIBA
11/2008
1NucleosidesIBA
12/2007

Therapy/Procedure

2Therapeutics
01/2020 - 11/2016
2Intravenous Injections
11/2013 - 06/2011
1Oral Administration
11/2008